US Stock MarketDetailed Quotes
APLM Apollomics
- 0.194
- +0.098+102.09%
Close Nov 18 16:00 ET
- 0.177
- -0.017-8.67%
Pre 05:29 ET
21.27MMarket Cap-372P/E (TTM)
0.360High0.147Low1.68BVolume0.184Open0.096Pre Close388.32MTurnover2922.44%Turnover RatioLossP/E (Static)109.73MShares1.23052wk High1.02P/B11.13MFloat Cap0.08052wk Low--Dividend TTM57.45MShs Float49.000Historical High--Div YieldTTM221.59%Amplitude0.080Historical Low0.231Avg Price1Lot Size
About Apollomics Company
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Company Profile
SymbolAPLM
Company NameApollomics
Listing DateNov 26, 2021
Founded2015
CEODr. Guo-Liang Yu, PhD
MarketNASDAQ
Employees45
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 220
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-209-4055
Websitehttp://www.apollomicsinc.com
Company Executives
- Name
- Position
- Salary
- Dr. Guo-Liang Yu, PhD
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Lijuan Jane Wang, PhD
- Chief Scientific Officer
- --
- Dr. Kin-Hung Peony Yu, M.D.
- Chief Medical Officer
- --
- Dr. Sanjeev Redkar, PhD
- President, Director and Principal Financial Officer
- --
- Dr. Jonathan Jian Wang, PhD
- Director
- --
- Wendy Hayes
- Director
- --
- Glenn S. Vraniak
- Independent Director
- --
- Dr. Hong-Jung Moses Chen, PhD
- Independent Director
- --
- Dr. Kenneth C. Carter, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data